Percentage of disturbance observations in which a particular disturbance intensity was observed, per species, drone type and drone flight altitude. by Estefania Velilla (22566709)

The conserved phenylalanine residue in PRMT5 is critical for inhibition by the five compounds. by Gui-Mei Kong (4353751)

“…<p>A, DS-PAGE of recombinant wild type (WT) and F225M mutant (MT) PRMT5. …”

S5 Fig - by Kristen L. Lokken-Toyli (9455263)

IC₅₀ of indole alkaloid against alpha-glucosidase [26]. by Atikarn Janthongkaw (17020498)

Mean persistence (±SE) of GO and GO-GA NPs on <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)

Mice treated with antibiotics have decreased total inflammatory cell influx as compared to saline treated animals; though LZD treated animals have lower number of neutrophils in BA... by Urvashi Bhan (247436)

Decreased retinal cell density is associated with increased cell death in <i>Lrp2</i>^{<i>FoxG1</i>.<i>cre-KO</i>} mutant eyes. by Olivier Cases (760028)

Concentration of DRS-B2 and [W/F]³-DRS-B2 that inhibits 50% of cell growth (GI₅₀) extracted from Fig 12. by Célia Dos Santos (306471)

Variable importance metric as measured by mean decrease in gini index (standardized between 0 and 100) for internalizing problem behavior, based on random forest with the number of variables sampled at each split (mtry) = 5, and number of trees (ntree) = 100 fitted on the entire dataset. by Samrachana Adhikari (7818143)

Sustainable Production of Polyamide 6 Fibers: Direct Melt Spinning and Efficient Reuse of Residual Oligomers during Polymerization by Shengming Zhang (14662719)

Subjects:

Molecular signaling in response to high glucose in endothelial cells. by Haroldo A. Toque (447341)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

Subjects:

CONSORT flow diagram. by Judith I. Tsui (5983160)

Subjects:

Adverse events in placebo arm. by Judith I. Tsui (5983160)

Subjects:

Medication tolerability, discontinuations, adherence over the 8-week study period. by Judith I. Tsui (5983160)

Subjects:

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

Subjects:

Medication satisfaction over 8-week study medication period. by Judith I. Tsui (5983160)

Subjects:

Main results: Changes in primary and secondary outcomes from baseline to 8 weeks in the PETER PAIN trial. by Judith I. Tsui (5983160)

Subjects:

Baseline characteristics of PETER PAIN study participants: People with HIV, chronic pain, and heavy alcohol use (n = 45). by Judith I. Tsui (5983160)

Subjects:

NO levels in aorta. by Haroldo A. Toque (447341)